Meningococcus Carriers

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Meningococcus B

Between 13 different serogroups of N. meningitidis, identified according to the capsular polysaccharide’s antigenic structure, only 5 (A, B, C, W-135 and Y) are clinically relevant and responsible for 90% cases of meningococcal invasive disease. In Italy, serogroup B is the principal cause of invasive meningococcal disease [1]. There are two types of tetravalent vaccines for serogroups A, C, W-...

متن کامل

A Report on Antimeningitis Vaccination and Observations on Agglutinins in the Blood of Chronic Meningococcus Carriers

1. A meningococcus vaccine suspended in salt solution has been given subcutaneously as a prophylactic to about 3,700 volunteers in three injections of 2,000 million, 4,000 million, and 4,000 or 8,000 million cocci at weekly intervals. 2. These doses rarely caused more than the mildest local and general reactions. Exceptionally a more severe reaction emphasized the presence of an unusual individ...

متن کامل

Studies on Meningococcus Infection

Precipitin tests, carried out on the cerebrospinal fluid from cases of meningococcal meningitis with monovalent sera, demonstrate the presence in that fluid of type-specific precipitinogens of the meningococcus. Negative results are secured when the spinal fluid is obtained after the commencement of intrathecal serum treatment and also occasionally when the numbers of infecting organisms are ve...

متن کامل

The meningococcus tamed?

Serogroup B Neisseria meningitidis is a frequent cause of invasive meningococcal disease, yet there are no effective vaccines suitable for routine immunisation. Limited efficacy has been shown with meningococcal outer membrane vacccines in children 4 years and older. Here we review the status of current research and consider new approaches to development of meningococcal serogroup B vaccines.

متن کامل

Immunisation against meningococcus B.

www.thelancet.com Vol 382 September 7, 2013 857 in 2000 under circumstances of uncertainty about efficacy and low (but in that case rising) disease incidence. A decision to introduce the Novartis vaccine, which is not really a meningococcus B but actually a broader, generic meningococcal vaccine, and to give it to adolescents and young adults who have the highest carriage rates could have been ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: The Journal of Nervous and Mental Disease

سال: 1918

ISSN: 0022-3018

DOI: 10.1097/00005053-191808000-00007